|
|
||||||||
The Journal of Immunology, Vol 156, Issue 5 2004-2008, Copyright © 1996 by American Association of Immunologists
ARTICLES |
RW Crowley, P Secchiero, D Zella, A Cara, RC Gallo and O Lusso
Laboratory of Tumor Cell Biology, National Cancer Institute, Bethesda, MD 20894, USA.
Human herpesvirus 7 (HHV-7) uses CD4 as a cellular membrane receptor and thereby interferes with infection of CD4+ T cells by HIV-1. We studied the interactions between HHV-7 and a macrophage-tropic HIV-1 isolate (HIV-1BaL) in terminally differentiated human peripheral blood monocyte-derived macrophages, another critical target for infection by HIV-1 in vivo. Exposure of macrophages to HHV-7 alone yielded no signs of virus replication or cytopathic effects. Nevertheless, when macrophages were pre-exposed to either live or UV-inactivated HHV-7 and subsequently infected with HIV-1BaL, a significant dose-dependent inhibition of HIV-1 replication was documented. At day 7 postinfection, the average level of HIV-1 p24 Ag in cultures from five different donors was reduced by 91.7 +/- 8.3% by pretreatment with live HHV-7 and by 91.8 +/- 8.2% by pretreatment with UV-inactivated HHV-7. Moreover, the synthesis of HIV-1 proviral DNA in macrophages pretreated with HHV- 7 was completely inhibited during the early stages after infection, suggesting that HHV-7 blocks HIV-1 at the level of interaction with the CD4 receptor. Consistent with this concept, both macrophage and CD4+ T cell cultures with pre-established HIV-1 infection were not susceptible to inhibitory effects of HHV-7. The proliferative response of PBMC to mitogens was only marginally inhibited by exposure to HHV-7 before mitogen stimulation, indicating that the inhibition of HIV-1 infection was not due to a negative effect on cell proliferation. These data demonstrate that HHV-7 is a powerful inhibitor of HIV-1 infection in cells of the mononuclear phagocytic lineage, despite its inability to replicate actively in such cells.
This article has been cited by other articles:
![]() |
K. Nakano, K. Tadagaki, Y. Isegawa, M. M. Aye, P. Zou, and K. Yamanishi Human Herpesvirus 7 Open Reading Frame U12 Encodes a Functional {beta}-Chemokine Receptor J. Virol., July 15, 2003; 77(14): 8108 - 8115. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, L. de Bolle, S. Aquaro, A. van Lommel, E. De Clercq, and D. Schols Productive Infection of Primary Macrophages with Human Herpesvirus 7 J. Virol., November 1, 2001; 75(21): 10511 - 10514. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, S. Hatse, E. De Clercq, and D. Schols CXC-Chemokine Receptor 4 Is Not a Coreceptor for Human Herpesvirus 7 Entry into CD4+ T Cells J. Virol., February 15, 2000; 74(4): 2011 - 2016. [Abstract] [Full Text] |
||||
![]() |
H. Romi, O. Singer, D. Rapaport, and N. Frenkel Tamplicon-7, a Novel T-Lymphotropic Vector Derived from Human Herpesvirus 7 J. Virol., August 1, 1999; 73(8): 7001 - 7007. [Abstract] [Full Text] |
||||
![]() |
M. Yasukawa, A. Hasegawa, I. Sakai, H. Ohminami, J. Arai, S. Kaneko, Y. Yakushijin, K. Maeyama, H. Nakashima, R. Arakaki, et al. Down-Regulation of CXCR4 by Human Herpesvirus 6 (HHV-6) and HHV-7 J. Immunol., May 1, 1999; 162(9): 5417 - 5422. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Kempf, V. Adams, N. Wey, R. Moos, M. Schmid, E. Avitabile, and G. Campadelli-Fiume CD68+ cells of monocyte/macrophage lineage in the environment of AIDS-associated and classic-sporadic Kaposi sarcoma are singly or doubly infected with human herpesviruses 7 and 6B PNAS, July 8, 1997; 94(14): 7600 - 7605. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-M. Huang, M.-F. Chao, M.-Y. Chen, H.-m. Shih, Y.-P. Chiang, C.-Y. Chuang, and C.-Y. Lee Reciprocal Regulatory Interaction between Human Herpesvirus 8 and Human Immunodeficiency Virus Type 1 J. Biol. Chem., April 13, 2001; 276(16): 13427 - 13432. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |